医薬品業界のライセンシング契約 (2020-2025年)

本レポートでは、2020年から2025年までの医薬品業界のライセンシング契約の詳細を提供しています。当事者間で発表されたライセンシング契約の支払い条件へのアクセスを提供し、支払い条件やその他の取引条件について有益な洞察を提供します。

主な利点

本レポートは、読者に以下の主な利点を提供します：

• 2020年以降の契約動向への理解
• ライセンシング契約の閲覧
• ベンチマーク分析：取引の市場価値の把握
• 財務条件：一時金、マイルストーン、ロイヤルティに関する情報
• 契約ディレクトリ：企業別 (A～Z)、治療分野別、技術タイプ別
• 主要契約：金額別
• 最も活発な契約締結企業の特定
• 各取引の資産および契約条件の特定
• 契約文書へのアクセス：契約構造に関する洞察
• デューデリジェンス：提携企業に対する自社の契約条件の適合性の評価
• 数百時間の調査時間を節約可能

調査範囲

• バイオ製薬業界におけるライセンシング契約の動向
• ライセンシング契約構造の概要
• 製薬およびバイオテクノロジー分野におけるライセンシング契約記録のディレクトリ
• 契約金額が大きい主要なライセンシング契約
• 最も活発にライセンシング契約を行っている企業
• 主要なライセンシング提携リソース

利用可能な契約のリスト：

• 企業 (A～Z)
• 契約総額
• 治療分野
• 技術タイプ

目次

エグゼクティブサマリー

第1章 イントロダクション

第2章 ライセンシング取引の動向

• ライセンシング契約の定義
• 2020年以降のライセンシング契約の動向
  • 2020～2025年におけるライセンシング契約：年別
  • 2020～2025年におけるライセンシング契約：開発段階別
  • 2020～2025年におけるライセンシング契約：業界別
  • 2020～2025年におけるライセンシング契約：治療領域別
  • 2020～2025年におけるライセンシング契約：技術タイプ別
  • 2020～2025年におけるライセンシング契約：最も活発な企業別
• ライセンシング提携契約を締結する理由
• ライセンシング契約の未来

第3章 ライセンシング契約の構造：概要

• ライセンシング契約の構造

第4章 主要なライセンシング契約

• トップライセンシング契約：金額別

第5章 最も活発なライセンシング契約企業：トップ25社

• 最も活発なライセンシング契約企業：トップ25社

第6章 契約ディレクトリを含むライセンシング契約

• 2020年から2025年までの契約を含むライセンシング契約
• 契約ディレクトリ
• 契約ディレクトリ- 企業別ライセンシング契約 (A-Z)
• 契約ディレクトリ- 治療領域別のライセンシング契約
• 契約ディレクトリ- 技術タイプ別のライセンシング契約
• Biopharma Researchについて
• 現在の提携
• 現在の契約
• Current Partneringからの最近のレポートタイトル

Licensing Deals in Pharmaceuticals provides a detailed understanding and analysis of how and why companies enter licensing deals.

Fully revised and updated, the report provides details of licensing deals from 2020 to 2025.

The report provides access to licensing deal payment terms as announced between the parties. This data provides useful insight into the payment and other deal terms.

Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered and rights transferred - contract documents provide this insight where press releases and databases do not.

This report contains a comprehensive listing of licensing deals announced since 2020 as recorded in the Current Agreements deals and alliances database, including financial terms where available, plus links to online copies of actual licensing contract documents as submitted to the Securities Exchange Commission by companies and their partners.

The initial chapters of this report provide an orientation of licensing dealmaking and business activities.

Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview and analysis of the trends in licensing as well as a discussion on the merits of the type of deal.

Chapter 3 provides an overview of the structure of licensing deals.

Chapter 4 provides a review of the leading licensing deals since 2020. Deals are listed by headline value. Where the deal has an agreement contract published at the SEC a link provides online access to the contract via the Current Agreements deals and alliances database.

Chapter 5 provides a comprehensive listing of the top 25 most active licensing dealmaker companies. Each deal title links via Current Agreements deals and alliances database to an online version of the full deal record, and where available, the actual contract document, providing easy access to each deal record on demand.

Chapter 6 provides a comprehensive and detailed review of licensing deals organized by company A-Z, therapy, technology and industry type signed and announced since 2020 where a contract document is available. Contract documents provide an indepth insight into the actual deal terms agreed between the parties with respect to the licensing deal.

The deal directory includes a comprehensive listing of all licensing deals announced since 2020. Each listing is organized as a deal directory by company A-Z, therapeutic area and technology type. Each deal title links via hyperlink to an online version of the deal record including, where available, the actual contract document.

The report also includes numerous table and figures that illustrate the trends and activities in licensing dealmaking since 2020.

In conclusion, this report provides everything a prospective dealmaker needs to know about licensing alliances.

Key benefits

Licensing Deals in Pharmaceuticals provides the reader with the following key benefits:

• Understand deal trends since 2020
• Browse licensing deals
• Benchmark analysis - identify market value of transactions
• Financials terms - upfront, milestone, royalties
• Directory of deals by company A-Z, therapy focus and technology type
• Leading deals by value
• Most active dealmakers
• Identify assets and deal terms for each transaction
• Access contract documents - insights into deal structures
• Due diligence - assess suitability of your proposed deal terms for partner companies
• Save hundreds of hours of research time

Report scope

• Licensing Deals in Pharmaceuticals is intended to provide the reader with an in-depth understanding of the licensing trends and structure of deals entered into by leading biopharma companies worldwide.

Licensing Deals in Pharmaceuticals includes:

• Trends in licensing dealmaking in the biopharma industry
• Overview of licensing deal structure
• Directory of licensing deal records covering pharmaceutical and biotechnology
• The leading licensing deals by value
• Most active licensing dealmakers
• The leading licensing partnering resources

In Licensing Deals in Pharmaceuticals, the available deals are listed by:

• Company A-Z
• Headline value
• Therapeutic area
• Technology type
• Each deal title links via Weblink to an online version of the actual deal record, providing easy access to each contract document where available.
• Licensing Deals in Pharmaceuticals provides comprehensive access to available records for licensing deals, including contract documents where available.

Analyzing contract agreements allows due diligence of:

• What are the rights granted or optioned?
• What rights are granted by the agreement?
• What exclusivity is granted?
• What is the payment structure for the deal?
• How are sales and payments audited?
• What is the deal term?
• How are the key terms of the agreement defined?
• How are intellectual property rights handled and owned?
• Who is responsible for commercialization?
• Who is responsible for development, supply, and manufacture?
• How is confidentiality and publication managed?
• How are disputes resolved?
• Under what conditions can the deal be terminated?
• What happens when there is a change of ownership?
• What sublicensing and subcontracting provisions have been agreed?
• Which boilerplate clauses does the company insist upon?
• Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
• Which jurisdiction does the company insist upon for agreement law?

Table of Contents

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in licensing dealmaking

• 2.1. Introduction
• 2.2. Definition of licensing deal
• 2.3. Trends in licensing deals since 2020
  • 2.3.1. Licensing dealmaking by year, 2020-2025
  • 2.3.2. Licensing dealmaking by phase of development, 2020-2025
  • 2.3.3. Licensing dealmaking by industry sector, 2020-2025
  • 2.3.4. Licensing dealmaking by therapy area, 2020-2025
  • 2.3.5. Licensing dealmaking by technology type, 2020-2025
  • 2.3.6. Licensing dealmaking by most active company, 2020-2025
• 2.4. Reasons for entering into licensing partnering deals
• 2.5. The future of licensing deals

Chapter 3 - Overview of licensing deal structure

• 3.1. Introduction
• 3.2. Licensing agreement structure

Chapter 4 - Leading licensing deals

• 4.1. Introduction
• 4.2. Top licensing deals by value

Chapter 5 - Top 25 most active licensing dealmakers

• 5.1. Introduction
• 5.2. Top 25 most active licensing dealmakers

Chapter 6 - Licensing deals including contracts directory

• 6.1. Introduction
• 6.2. Licensing deals with contracts 2020-2025
• Deal directory
• Deal directory - licensing dealmaking by companies A-Z
• Deal directory - licensing dealmaking by therapy area
• Deal directory - licensing dealmaking by technology type
• About Biopharma Research
• Current Partnering
• Current Agreements
• Recent report titles from Current Partnering

TABLE OF FIGURES

• Figure 1: Definition of licensing
• Figure 2: Trends in licensing deal announcements, 2020-2025
• Figure 3: Licensing deals signed at each phase of development, 2020-2025
• Figure 4: Licensing deals by industry sector, 2020-2025
• Figure 5: Licensing deals by therapy area, 2020-2025
• Figure 6: Licensing deals by technology type, 2020-2025
• Figure 7: Top 25 most active licensing dealmakers, 2020-2025
• Figure 8: Top licensing deals by value, 2020-2025
• Figure 9: Most active licensing dealmakers, 2020-2025